The inhibiTion of dipeptidyl peptidase-4 ( DPP-4 ) increases the concentration of glucagon-like peptide-1 , A randomized , placebo-controlled , double-blind , phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes